TARO
Taro Pharmaceutical Industries Ltd. · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website aro.com
- Employees(FY) 1554
- ISIN IL0010827181
Performance
-0.47%
1W
+0.36%
1M
-0.33%
3M
+20.46%
6M
+1.2%
YTD
+46.04%
1Y
Profile
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.
Investment Analysis Report: TARO
Overview
In this investment analysis report, we will delve into a comprehensive evaluation of TARO, a pharmaceutical company operating in the Health Technology sector. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, capital expendi...
Technical Analysis of TARO 2024-05-03
Overview:
In analyzing the technical indicators for TARO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Indicators...
Recent News & Updates
- 2024-05-08 09:07
- 2024-05-07 21:07
- 2024-04-15 08:00
- 2024-04-14 20:00
- 2024-03-06 12:54
- 2024-03-05 23:30
- 2024-01-30 07:00
- 2024-01-30 00:41
- 2024-01-30 00:18
- 2024-01-29 18:00
- 2024-01-29 10:01
- 2024-01-25 17:13
Taro: Fiscal Q3 Earnings Snapshot(Associated Press Finance)
- 2024-01-25 17:06
Taro Provides Results for December 31, 2023(Business Wire)
- 2024-01-25 04:06
Taro Provides Results for December 31, 2023(Businesswire)
- 2024-01-24 19:03
- 2024-01-23 01:45
- 2024-01-22 21:30
- 2024-01-19 22:29
- 2024-01-19 16:15
Taro to Release Third Quarter Results on January 25, 2024(Business Wire)
- 2024-01-19 03:15
- 2024-01-18 00:52
- 2024-01-17 16:30
- 2024-01-17 03:30
Taro Announces Merger Agreement with Sun Pharma(Prnewswire)
- 2023-12-29 09:48
- 2023-12-28 11:13
- 2023-12-26 11:32
- 2023-12-26 10:51
- 2023-12-22 10:07
- 2023-10-26 17:12
Taro: Fiscal Q2 Earnings Snapshot(Associated Press Finance)
- 2023-10-26 17:00
Taro Provides Results for September 30, 2023(Business Wire)
Page 1 of 5
previousnext